» Articles » PMID: 35298334

Prevention of the Foreign Body Response to Implantable Medical Devices by Inflammasome Inhibition

Abstract

SignificanceImplantable electronic medical devices (IEMDs) are used for some clinical applications, representing an exciting prospect for the transformative treatment of intractable conditions such Parkinson's disease, deafness, and paralysis. The use of IEMDs is limited at the moment because, over time, a foreign body reaction (FBR) develops at the device-neural interface such that ultimately the IEMD fails and needs to be removed. Here, we show that macrophage nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome activity drives the FBR in a nerve injury model yet integration of an NLRP3 inhibitor into the device prevents FBR while allowing full healing of damaged neural tissue to occur.

Citing Articles

Engineered immunological niche directs therapeutic development in models of progressive multiple sclerosis.

Rad L, Hughes K, Wheeler S, Decker J, Orbach S, Galvan A Proc Natl Acad Sci U S A. 2025; 122(7):e2409852122.

PMID: 39937858 PMC: 11848328. DOI: 10.1073/pnas.2409852122.


A Combinatory Therapy of Metformin and Dexamethasone Reduces the Foreign Body Reaction to Intraneural Electrodes.

Rodriguez-Meana B, Del Valle J, Navarro X Cells. 2025; 13(24.

PMID: 39768202 PMC: 11726768. DOI: 10.3390/cells13242112.


Thin-film implants for bioelectronic medicine.

Oldroyd P, El Hadwe S, Barone D, Malliaras G MRS Bull. 2024; 49(10):1045-1058.

PMID: 39397879 PMC: 11469980. DOI: 10.1557/s43577-024-00786-7.


Effects of Micromachining on Anti-oxidant Elution from a Mechanically-Adaptive Polymer.

Mueller N, Kim Y, Ocoko M, Dernelle P, Kale I, Patwa S J Micromech Microeng. 2024; 34(3).

PMID: 38586082 PMC: 10996452. DOI: 10.1088/1361-6439/ad27f7.


Practical Guidance for Clinical Microbiology Laboratories: Microbiologic diagnosis of implant-associated infections.

Ann Azad M, Patel R Clin Microbiol Rev. 2024; 37(2):e0010423.

PMID: 38506553 PMC: 11237642. DOI: 10.1128/cmr.00104-23.


References
1.
Zhu Z, Ding J, Shankowsky H, Tredget E . The molecular mechanism of hypertrophic scar. J Cell Commun Signal. 2013; 7(4):239-52. PMC: 3889252. DOI: 10.1007/s12079-013-0195-5. View

2.
Christo S, Diener K, Manavis J, Grimbaldeston M, Bachhuka A, Vasilev K . Inflammasome components ASC and AIM2 modulate the acute phase of biomaterial implant-induced foreign body responses. Sci Rep. 2016; 6:20635. PMC: 4748295. DOI: 10.1038/srep20635. View

3.
Favor O, Pestka J, Bates M, Lee K . Centrality of Myeloid-Lineage Phagocytes in Particle-Triggered Inflammation and Autoimmunity. Front Toxicol. 2022; 3:777768. PMC: 8915915. DOI: 10.3389/ftox.2021.777768. View

4.
Chung L, Maestas Jr D, Housseau F, Elisseeff J . Key players in the immune response to biomaterial scaffolds for regenerative medicine. Adv Drug Deliv Rev. 2017; 114:184-192. DOI: 10.1016/j.addr.2017.07.006. View

5.
Coll R, Robertson A, Chae J, Higgins S, Munoz-Planillo R, Inserra M . A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015; 21(3):248-55. PMC: 4392179. DOI: 10.1038/nm.3806. View